OBESITY TREATMENT Russian patent published in 2024 - IPC A61K31/437 A61P3/04 

Abstract RU 2822679 C2

FIELD: medicine.

SUBSTANCE: group of inventions relates to a method of treating a condition selected from a group consisting of obesity, overweight, type II diabetes mellitus and metabolic syndrome, in a mammal, including a human, involving administering to a mammal subject in need thereof, a therapeutically effective amount of a pharmaceutical composition comprising: (a) compound 14-3: or a pharmaceutically acceptable salt thereof, which is effective for treating or preventing a condition selected from a group consisting of obesity, overweight, type II diabetes mellitus and metabolic syndrome, mammal, including human, and (b) the pharmaceutically acceptable excipient, carrier or diluent also relates to a method of treating a condition associated with increased intracellular accumulation of triglycerides in liver cells of a mammal, including a human, where said condition is selected from the group consisting of obesity, overweight, type II diabetes mellitus and metabolic syndrome, wherein said method involves administering to a mammal subject in need thereof a therapeutically effective amount of a pharmaceutical composition comprising: compound selected from a group consisting of: and or a pharmaceutically acceptable salt thereof; and (b) a pharmaceutically acceptable excipient, carrier or diluent.

EFFECT: group of inventions provides treating a condition selected from a group consisting of obesity, overweight, type II diabetes mellitus and metabolic syndrome in a mammal.

7 cl, 34 dwg, 10 ex

Similar patents RU2822679C2

Title Year Author Number
TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE 2019
  • Li, Chian Dzh.
  • Derdak, Zoltan
  • Lyu, Tszifen
RU2815647C2
NOVEL IMMUNE SYSTEM MODULATORS RELATED APPLICATIONS 2012
  • Lipford Grejson B.
  • Zepp Charlz M.
RU2606114C2
IMIDAZOQUINOLINE SUBSTITUTED PHOSPHORIC ACID ESTER AS AGONIST, ITS PREPARATION AND USE 2020
  • Lv, Binhua
  • Cui, Dawei
  • Chai, Chuanke
  • Liu, Ruifeng
  • Sheng, Zelin
RU2812182C1
MACROCYCLIC SERINE PROTEASE INHIBITORS 2009
  • Parsi Kristof Klod
  • Aleksandr Fransua-Rene
  • Sjurlero Dominik
  • Derok Mishel'
  • Lerua Frederik
RU2490272C2
NOVEL CYCLOSPORIN DERIVATIVES FOR TREATMENT AND PREVENTION OF VIRAL INFECTIONS 2011
  • Su Chzhuan
  • Long Chzhenjuj
  • Khuan Chzhennjan
  • Jan Sujchzhou
RU2601742C2
5,5-CONDENSED ARYLENE OR HETEROARYLENE HEPATITIS C VIRUS INHIBITORS 2010
  • Dusson Siril B.
  • Djukan David
  • Parsi Kristof Klod
  • P'Erra Kler
  • Aleksandr Fransua-Rene
  • Brand Gijom
  • Da Kosta Daniel'
  • Raali Usin
  • Paparehn Zhan-Loran
  • Derok Mishel'
  • Konvar T'Erri
  • Sjurlero Dominik
RU2554087C2
BENZIMIDAZOLE DERIVATIVES AS ERBB TYROSINE KINASE INHIBITORS FOR TREATING CANCER 2015
  • Long, Yun
RU2741914C2
HETEROCYCLIC AMIDE COMPOUND, PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, METHOD FOR PREPARATION AND USE THEREOF 2020
  • Duan, Wenhu
  • Geng, Meiyu
  • Zhang, Huibin
  • Xie, Zuoquan
  • Zhou, Jinpei
  • Yang, Yifei
  • Wang, Xiyuan
  • Yang, Xiaojun
  • Zhang, Yan
  • Hu, Zhaoxue
  • Ding, Jian
RU2823875C1
(ALPHA-SUBSTITUTED ARALKYLAMINO- AND HETEROARYLALKYLAMINO)PYRIMIDINYL- AND 1,3,5-TRIAZINYLBENZIMIDAZOLES, PHARMACEUTICAL COMPOSITIONS THEREOF AND USE THEREOF IN TREATING PROLIFERATIVE DISEASES 2012
  • Braun S. Devid
  • Mettyuz Devid Dzh.
RU2608742C2
N1-(4-(5-(CYCLOPROPYLMETHYL)-1-METHYL-1H-PYRAZOLE-4-YL)PYRIDINE-2-YL)CYCLOHEXANE-1,4-DIAMINE DERIVATIVES AND RELATED COMPOUNDS AS INHIBITORS OF CK1 AND/OR IRAK1 FOR THE TREATMENT OF CANCER 2018
  • Li, Dansu
  • Snir-Alkalaj, Irit
  • Vakka, Jozef
  • Ben Neriakh, Jinon
  • Venkatak-Ialam, Avantika
RU2761457C2

RU 2 822 679 C2

Authors

Li, Chian Dzh.

Derdak, Zoltan

Stevanovich, Darko

Lyu, Tszifen

Dates

2024-07-11Published

2019-09-18Filed